The greying of cardiology: implications for management.
"The development of new therapies and devices should reflect the dominant population that will ultimately use them--in the case of cardiovascular therapies and devices, this is exemplified by elderly patients"
Wenger
Nanette K
NK
D000367:Age Factors; D000368:Aged; D002309:Cardiology / Q000639:trends*; D019456:Health Transition; D006331:Heart Diseases / Q000628:therapy*; D006801:Humans; D018579:Patient Selection; D035703:Therapies, Investigational